Skanray Technologies IPO analysis @ Chanakyanipothi.com , India`s Oldest & most Trusted Investment Blog.Operational since 8th December 1999, We are the Only Investment Platform in India, which has successfully completed 21 Years
Skanray Technologies Grey Market News Today #
Grey Market Premium Rs. –
Application Rates :Rs. –
Subject to Rates : Rs. –
Skanray Technologies Company Details
Skanray Technologies is among the key Indian medical device players . It is a multi-product company offering a diversified portfolio of products, including patient monitoring systems, cardiology devices, respiratory management systems and radiology/ imaging systems .In Fiscal 2020 it sold its products and services to over 1,830 customers in 20 countries. It has an extensive in-house research and development team that has been granted 27 patents, 49 trademarks, and 11 design registrations as of December 31, 2020.
Its product-driven acquisitions include the acquisition of the medical equipment business of Larsen and Toubro Limited to grow its PMS and ESU product portfolio, which form part of its critical care segment, and to leverage the pan-India distribution network of Larsen and Toubro’s business. It acquired Pricol Engineering Industries Limited’s medtech business in 2013 to gain access to their RMS product portfolio. Its market-driven acquisitions include the acquisition of CEI-Italy , an Italian X-ray tube manufacturer, to gain a presence in the European market and to vertically integrate its radiology product line for which X-ray tubes are a critical component. The acquisition of Cardia International A/S, manufacturer of AED, was similarly driven to gain access to a distribution network in Europe.
Skanray Technologies has a well-diversified portfolio of products that can be classified into three broad categories, critical care products, radiology products and respiratory management systems. Its critical care products include patient monitoring systems, cardiology devices, syringe-pumps, and electro-surgical units. Its radiology products include mobile and fixed X-ray systems, DR systems, surgical C-arms, and dental x-ray systems. Its portfolio of respiratory management systems includes anaesthesia delivery systems and ICU ventilator systems. Its products have received several certifications including US FDA, CE and certain of its processes are ISO certified.
It capitalized on this platform-based model most recently by entering into a licensing framework with Bharat Electronics Limited to manufacture 30,000 ventilators (model CV-200) during the initial months of the COVID-19 pandemic in India. These ventilators have been distributed to various government hospitals in India.
It has three manufacturing facilities, of which two are in India and one in Italy, that had an
aggregate installed manufacturing capacity of 49,000 units per annum. Through the acquisition of SHGPL it acquired two more facilities, one in Italy and one in the Netherlands, that had an aggregate installed manufacturing capacity of 5,200 units per annum, as of December 31, 2020. Each of its facilities is periodically subject to third-party audits and manufactures US FDA and CE certified devices. In addition, with facilities located in Europe, it is able to produce ‘Made in Europe’ devices that get preference in certain markets within Europe, giving us a competitive advantage over manufacturers outside Europe.
Owing to its portfolio of globally certified products and manufacturing facilities, it has been able to build an extensive global and pan-India distribution network.
For more information, click www.skanray.com
The Promoters of Skanray Technologies
vishwaprasad Alva, Agnus Capital LLP, Chayadeep Properties Pvt ltd & Skanray Healthcare Partners LLP
Skanray Technologies IPO Main Objects
The Offer comprises of the Fresh Issue and Offer for Sale.
The Company proposes to utilise the Net Proceeds towards funding of the following objects:1. Funding inorganic growth 2. Funding working capital requirements of the Company; 3. Investment in its subsidiaries; 4. Funding capital expenditure requirements of the Company;
Skanray Technologies IPO Details
IPO opens on (?) Dec, 2021
IPO closes on (?) Dec,2021
Issue Type: Book Built Issue IPO
Issue : up to (?) Shares /Rs (?) Crore
* Fresh Issue of (?) Sh/ Rs.150 Cr
* Offer for Sale Up to 14,106,347 Sh/ Rs. (?) Cr
Face Value per share : Rs. 10
Skanray Technologies IPO Price Band Per Equity Share: Rs. (?)
Skanray Technologies IPO Retail Lot Size (?) Shares
Skanray Technologies Listing will at BSE,NSE
Shares offered to
QIB (?%) ?Shares = Rs (?) Cr
NII (?%) ?Shares = Rs (?) Crs
RII (?%) ? Shares = Rs (?) Crs
Lot size: (?) Shares = (?) Forms
Min Retail Application : (?) Sh , Rs. (?)
Max Retail Application : (?) Sh, Rs (?)
Skanray Technologies IPO Tentative timeTable
Skanray Technologies IPO Allotment on ? 2021
Unblocking of ASBA ? 2021
Credit to Demat Accounts ? 2021
Data Patterns Listing on ? 2021
Skanray Technologies IPO Financial & Analytical Ratios
Earnings per Share 2019-20 Rs 1.34
Earnings per Share 2020-21,Rs (?)
Earnings per Share 2021-22 6M Rs ?
Book Value of the Share as on 31.3.2020 Rs 13.60
Return on Net Worth: 19-20 12.29 %
Return on Net Worth: 20-21: (?) %
Return on Net Worth: 20-21 6M:( N.A.) %
Equity Shares prior to the IPO : 24,237,341 Shares
Upper Price Band/last EPS:
Upper offer price/Book Value Ratio
Upper offer price/BV after IPO Ratio:
Skanray Technologies IPO Peer Comparison:
There are no listed peers for this Company.
Skanray Technologies IPO Lead Managers
Motilal Oswal Investment Advisors,Nomura Financial Advisory,ICICI Securities,
Registrar to Skanray Technologies IPO
Linkintime India pvt ltd.
Registered Office of Skanray Technologies
Plot No 15-17 Hebbal Industrial Area, Mysore – 570 016
Company Secretary & Compliance Officer : Bhagya M G
#This is only coverage of News related to Grey Market . We donot deal in Grey market premium, nor we recommend dealing in Grey Market. Investment decision based on Grey Market trends can be faulty.